Microvasculature in Brain Biopsy Specimens from Patients with Alzheimer's Disease: An Immunohistochemical and Ultrastructural Study

References

• Castaño EM, Frangione B. Human amyloidosis, Alzheimer disease and related disorders. Lab Invest. 1988; 58: 122–132
   PubMed Web of Science ®Google Scholar
• Glenner GG. Alzheimer's disease: its proteins and genes. Cell. 1988; 52: 307–308
   PubMed Web of Science ®Google Scholar
• Roberts GW, Lofthouse R, Allsop D, et al. CNS amyloid proteins in neurodegenerative diseases. Neurology 1988; 38: 1534–1540
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging 1989; 10: 387–395
   PubMed Web of Science ®Google Scholar
• Vinters HV. Amyloid and the central nervous system: the neurobiology, genetics and immunocytochemistry of a process important in neurodegenerative diseases and stroke. Neuropathology., PA Cancilla, FS Vogel, N Kaufman. Williams & Wilkins, Baltimore, Md 1990; 55–85
   Google Scholar
• Vinters HV, Miller BL, Pardridge WM. Brain amyloid and Alzheimer disease. Ann Intern Med. 1988; 109: 41–54
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984; 120: 885–890
   PubMed Web of Science ®Google Scholar
• Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984; 122: 1131–1135
   PubMed Web of Science ®Google Scholar
• Masters CL, Simms G, Weinman NA, Multhaup G, McDonaid BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245–4249
   PubMed Web of Science ®Google Scholar
• Pardridge WM, Vinters HV, Yang J, et al. Amyloid angiopathy of Alzheimer's disease: amino acid composition and partial sequence of a 4200-dalton peptide isolated from cortical microvessels. J Neurochem. 1987; 49: 1394–1401
   PubMed Web of Science ®Google Scholar
• Roher A, Wolfe D, Palutke M, KuKuruga D. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 1986; 83: 2662–2666
   PubMed Web of Science ®Google Scholar
• Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol. 1988; 24: 50–56
   PubMed Web of Science ®Google Scholar
• Torack RM. Adult dementia: history, biopsy, pathology. Neurosurgery. 1979; 4: 434–442
   PubMed Web of Science ®Google Scholar
• Hulette CM, Earl NL, Crain BJ. Evaluation of cerebral biopsies for the diagnosis of dementia. Arch Neurol. 1992; 49: 28–31
   PubMedGoogle Scholar
• Read SL, Frazee J, Shapira J, Smith C, Cummings JL, Tomiyasu U. Intracerebroventricular bethanechol for Alzheimer's disease. Variable dose-related responses. Arch Neurol. 1990; 47: 1025–1030
   PubMedGoogle Scholar
• Stewart PA, Hayakawa K, Akers M-A, Vinters HV. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest. 1992; 67: 734–742
   PubMed Web of Science ®Google Scholar
• Secor DL, Read SL, Frazee JG, et al. Brain biopsies from patients with Alzheimer disease. Immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol. 1989; 48: 326, Abstract
   Web of Science ®Google Scholar
• Hunter EE. Practical Electron Microscopy. A Beginner's Illustrated Guide. Praeger;, New York, NY 1984
   Google Scholar
• Vinters HV, Pardridge WM, Secor DL, Ishii N. Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am J Pathol. 1988; 133: 150–162
   PubMed Web of Science ®Google Scholar
• Vinters HV, Pardridge WM, Yang J. Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. Hum Pathol. 1988; 19: 214–222
   PubMed Web of Science ®Google Scholar
• Vinters HV, Nishimura GS, Secor DL, Pardridge WM. Immunoreactive A4 and γ-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol. 1990; 137: 233–240
   PubMed Web of Science ®Google Scholar
• Vinters HV, Secor DL, Pardridge WM, Gray F. Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with γ trace in patients with leukoencephalopathy. Ann Neurol. 1990; 28: 34–42
   PubMed Web of Science ®Google Scholar
• Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985; 42: 1097–1105
   PubMed Web of Science ®Google Scholar
• Stewart PA, Magliocco M, Hayakawa K, et al. A quantitative analysis of blood-brain barrier ultrastructure in the aging human. Microvasc Res. 1987; 33: 270–282
   PubMed Web of Science ®Google Scholar
• Claudio L, Brosnan CF, Dickson DW. Ultrastructure of the blood-brain barrier in Alzheimer's disease brain biopsies. Soc Neurosci Abstr. 1992; 18: 1493
   Google Scholar
• Fox JH, Penn R, Clasen R, Martin E, Wilson R, Savoy S. Pathological diagnosis in clinical typical Alzheimer's disease. N Engl J Med. 1985; 313: 1419–1420
   PubMed Web of Science ®Google Scholar
• McGeer PL, Kamo H, Harrop R, et al. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology 1986; 36: 1569–1574
   PubMed Web of Science ®Google Scholar
• Green MA, Stevenson LD, Fonseca JE, Wortis SB. Cerebral biopsy in patients with presenile dementia. Dis Nerv Syst. 1952; 13: 303–307
   PubMedGoogle Scholar
• Groves R, Møller J. The value of the cerebral cortical biopsy. Acta Neurol Scand. 1966; 42: 477–482
   Web of Science ®Google Scholar
• Kaufman HH, Catalano LW, Jr. Diagnostic brain biopsy: a series of 50 cases and a review. Neurosurgery. 1979; 4: 129–136
   PubMed Web of Science ®Google Scholar
• Kidd M. Alzheimer's disease—an electron microscopical study. Brain. 1964; 87: 307–320
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Mann DMA, et al. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatr. 1986; 49: 229–237
   PubMed Web of Science ®Google Scholar
• Smith WT, Turner E, Sim M. Cerebral biopsy in the investigation of presenile dementia. II. Pathological aspects. Br J Psychiatr. 1966; 112: 127–133
   PubMed Web of Science ®Google Scholar
• Terry RD, Gonatas NK, Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol. 1964; 44: 269–297
   PubMed Web of Science ®Google Scholar
• Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke. 1987; 18: 311–324
   PubMed Web of Science ®Google Scholar
• Arai H, Sagi N, Noguchi I, et al. An immunohistochemical study of β-protein in Alzheimer-type dementia brains. J Neurol. 1989; 236: 214–217
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E, Ohm T, Bohl J. Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques. Neurosci Lett. 1989; 103: 24–28
   PubMed Web of Science ®Google Scholar
• Gentleman SM, Bruton C, Allsop D, Lewis SJ, Polak JM, Roberts GW. A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits. Histochemistry 1989; 92: 355–358
   PubMedGoogle Scholar
• Ikeda S-I, Allsop D, Glenner GG. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid β-protein antibody. Lab Invest. 1989; 60: 113–122
   PubMed Web of Science ®Google Scholar
• Wisniewski HM, Wen GY, Kim KS. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol. 1989; 78: 22–27
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol. 1988; 77: 113–119
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Nakazato Y, Hirai S, Shoji M. Immunoelectron microscopic localization of amyloid beta protein in the diffuse plaques of Alzheimer-type dementia. Brain Res. 1990; 508: 320–324
   PubMed Web of Science ®Google Scholar
• Giaccone G, Tagliavini F, Linoli G, et al. Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett. 1989; 97: 232–238
   PubMed Web of Science ®Google Scholar
• Okazaki H, Reagan TJ, Campbell RJ. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc. 1979; 54: 22–31
   PubMed Web of Science ®Google Scholar
• Yong WH, Robert ME, Secor DL, Kleikamp TJ, Vinters HV. Cerebral hemorrhage with biopsy-proved amyloid angiopathy. Arch Neurol. 1992; 49: 51–58
   PubMedGoogle Scholar
• Joachim CL, Selkoe DJ. The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord. 1992; 6: 7–34
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues. Science 1990; 248: 1058–1060
   PubMed Web of Science ®Google Scholar
• Okoye MI, Watanabe I. Ultrastructural features of cerebral amyloid angiopathy. Hum Pathol. 1982; 13: 1127–1132
   PubMed Web of Science ®Google Scholar
• Vanley CT, Aguilar MJ, Kleinhenz RJ, Lagios MD. Cerebral amyloid angiopathy. Hum Pathol. 1981; 12: 609–616
   PubMed Web of Science ®Google Scholar
• Cancilla PA, Baker RN, Pollock PS, Frommes SP. The reaction of pericytes of the central nervous system to exogenous protein. Lab Invest. 1972; 26: 376–383
   PubMed Web of Science ®Google Scholar
• Sims DE. The pericyte—a review. Tissue Cell. 1986; 18: 153–174
   PubMed Web of Science ®Google Scholar
• Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural study of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. 1992; 84: 117–127
   PubMed Web of Science ®Google Scholar
• Pappolla MA, Omar RA, Vinters HV. Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol. 1991; 139: 599–607
   PubMed Web of Science ®Google Scholar
• Powers JM, Skeen JT. Ultrastructural heterogeneity in cerebral amyloid of Alzheimer's disease. Acta Neuropathol. 1988; 76: 613–623
   PubMed Web of Science ®Google Scholar
• Delacourte A, Defossez A, Persuy P, Peers MC. Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Arch A. 1987; 411: 199–204
   Web of Science ®Google Scholar
• Tabaton M, Mandybur TI, Perry G, Onorato M, Autilio-Gambetti L, Gambetti P. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol. 1989; 26: 771–778
   PubMed Web of Science ®Google Scholar
• Kawai M, Cras P, Siedlak S, et al. Role of vascular smooth muscle cells in amyloid deposition in cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 1990; 49: 331, Abstract
   Web of Science ®Google Scholar
• Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ. β amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol. 1992; 141: 249–259
   PubMed Web of Science ®Google Scholar
• Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986; 45: 79–90
   PubMed Web of Science ®Google Scholar
• Mandybur TI. Structural changes in cerebral vessels following amyloid deposition. Can J Neurol Sci. 1990; 17: 350, Abstract
   Google Scholar
• Regland B, Gottfries C-G. The role of amyloid β-protein in Alzheimer's disease. Lancet. 1992; 340: 467–469
   PubMed Web of Science ®Google Scholar
• Neurobiol Aging 1992; 13
   Web of Science ®Google Scholar
• Vinters HV, Reave S, Costello P, Girvin JP, Moore SA. Isolation and culture of cells derived from human cerebral microvessels. Cell Tissue Res. 1987; 249: 657–667
   PubMed Web of Science ®Google Scholar
• Frautschy SA, Cole GM, Baird A. Phagocytosis and deposition of vascular β-amyloid in rat brains injected with Alzheimer β-amyloid. Am J Pathol. 1992; 140: 1389–1399
   PubMed Web of Science ®Google Scholar
• Bell MA, Ball MJ. Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 1990; 11: 359–370
   PubMed Web of Science ®Google Scholar
• Miyakawa T, Sumiyoshi S, Murayama E, Deshimaru M. Ultrastructure of capillary plaque-like degeneration in senile dementia. Mechanism of amyloid production. Acta Neuropathol (Berl). 1974; 29: 229–236
   PubMed Web of Science ®Google Scholar
• Haan J, Lanser JBK, Zijderveld I, van der Does IGF, Roos RAC. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Arch Neurol. 1990; 47: 965–967
   PubMedGoogle Scholar
• Vinters HV. Cerebral amyloid angiopathy and Alzheimer's disease: two entities or one?. J Neurol Sci. 1992; 112: 1–3
   PubMed Web of Science ®Google Scholar
• Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol. 1989; 25: 12–25
   PubMed Web of Science ®Google Scholar
• St George-Hyslop PH, Haines JL, Farrer LA, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (London) 1990; 347: 194–197
   PubMed Web of Science ®Google Scholar
• Caputo CB, Salama AI. The amyloid proteins of Alzheimer's disease as potential targets for drug therapy. Neurobiol Aging 1989; 10: 451–461
   PubMed Web of Science ®Google Scholar
• Van Nostrand WE, Wagner SL, Haan J, Bakker E, Roos RAC. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid β-protein precursor. Ann Neurol. 1992; 32: 215–218
   PubMed Web of Science ®Google Scholar
• Farlow M, Ghetti B, Benson MD, Farrow JS, van Nostrand WE, Wagner SL. Low cerebrospinal-fluid concentrations of soluble amyloid β-protein precursor in hereditary Alzheimer's disease. Lancet. 1992; 340: 453–454
   PubMed Web of Science ®Google Scholar
• Wagner SL, Read SL, Van Nostrand WE, et al. Reduced levels of secreted amyloid β-protein precursor in CSF of pathologically confirmed Alzheimer's disease patients. Soc Neurosci Abstr. 1992; 18: 766
   Google Scholar